USRE48636EActiveUtility
Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban
Est. expiryJul 5, 2032(~6 yrs left)· nominal 20-yr term from priority
C07K 14/00A61K 38/16C07K 7/00A61K 38/005A61K 38/08C07K 14/47A61P 9/10C07K 7/06A61P 9/06A61P 9/04C07K 14/4703A61P 9/00A61P 37/06A61P 43/00
57
PatentIndex Score
0
Cited by
20
References
5
Claims
Abstract
The present invention relates to decoy peptide or polypeptide consisting of a peptide sequence represented by the following Formula I: X1-Ala-X2—X3-Ile-Glu-X4 (I). It is noteworthy that the decoy peptide or polypeptide of the present invention significantly elevates phosphorylation levels of PLB by inhibiting PP1-mediated dephosphorylation. In addition, the decoy peptide or polypeptide provides cardio-protective effects by restoring of SERCA2a activity and inotropic effect of enhancing myocardial contractility. The present invention will contribute greatly to the prevention or treatment of diseases associated with PLB.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a decoy peptide or polypeptide consisting of a peptide sequence represented by the following Formula I:
X 1 -Ala-X 2 —X 3 -Ile-Glu-X 4 (I)
wherein X 1 represents 0-1 amino acid residue(s), X 2 represents Ser, Glu, or Asp, X 3 represents Thr, Glu, or Asp and X 4 represents 0-3 amino acid residue(s), with the proviso that X 2 is not Ser when X 3 is Thr;
wherein the decoy peptide or polypeptide inhibits protein phosphatase 1 (PP1)-mediated dephosphorylation of phospholamban (PLB) by a competitive inhibition,
wherein neither X 1 nor X 4 comprise membrane-spanning domains and X 1 , if present, is not Tyr,
and wherein the decoy peptide or polypeptide is linked to a cell membrane-permeable peptide.
2. The pharmaceutical composition according to claim 1 , wherein X 1 is Arg.
3. The pharmaceutical composition according to claim 1 , wherein X 4 is Met, Met-Pro, or Met-Pro-Gln.
4. The pharmaceutical composition according to claim 1 , wherein the X 2 is Glu or Asp and X 3 is Thr, Glu, or Asp.
5. The pharmaceutical composition according to claim 1 , wherein the decoy peptide or polypeptide consists of the amino acid sequence selected from the group consisting of the amino acid sequences of SEQ ID NOs:1-6.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.